Zobrazeno 1 - 10
of 192
pro vyhledávání: '"Toine C G Egberts"'
Autor:
Laurent M A Favié, Floris Groenendaal, Marcel P H van den Broek, Carin M A Rademaker, Timo R de Haan, Henrica L M van Straaten, Peter H Dijk, Arno van Heijst, Jeroen Dudink, Koen P Dijkman, Monique Rijken, Inge A Zonnenberg, Filip Cools, Alexandra Zecic, Johanna H van der Lee, Debbie H G M Nuytemans, Frank van Bel, Toine C G Egberts, Alwin D R Huitema, PharmaCool study group
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211910 (2019)
ObjectiveMorphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study w
Externí odkaz:
https://doaj.org/article/d0c808959dbe4a898084ef6b50bb1751
Autor:
Kris van Keulen, Wilma Knol, Svetlana V Belitser, Irene J Zaal, Paul D van der Linden, Eibert R Heerdink, Toine C G Egberts, Arjen J C Slooter
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205637 (2018)
PURPOSE:To determine whether glucose variability is altered during delirium days compared to non-delirious days in critically ill patients with and without diabetes in the intensive care unit (ICU). MATERIALS AND METHODS:Critically ill patients with
Externí odkaz:
https://doaj.org/article/6471ea91d9684ad4be313593a834719d
Autor:
Fatma Karapinar-Çarkıt, Ronald van der Knaap, Fatiha Bouhannouch, Sander D Borgsteede, Marjo J A Janssen, Carl E H Siegert, Toine C G Egberts, Patricia M L A van den Bemt, Marieke F van Wier, Judith E Bosmans
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0174513 (2017)
To improve continuity of care at hospital admission and discharge and to decrease medication errors pharmaceutical care programs are developed. This study aims to determine the cost-effectiveness of the COACH program in comparison with usual care fro
Externí odkaz:
https://doaj.org/article/d5fc966e9ed243669f55a4701d7e724f
Autor:
A Clara Drenth-van Maanen, Rob J van Marum, Paul A F Jansen, Jeannette E F Zwart, Wouter W van Solinge, Toine C G Egberts
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128237 (2015)
To determine the prevalence, determinants, and potential clinical relevance of adherence with the Dutch dosing guideline in patients with impaired renal function at hospital discharge.Retrospective cohort study between January 2007 and July 2011.Acad
Externí odkaz:
https://doaj.org/article/405c425c9f0641be8af8a5bcd2bbd16c
Autor:
Diana A van Riet-Nales, Erwin G A W Römkens, Agnes Saint-Raymond, Piotr Kozarewicz, Alfred F A M Schobben, Toine C G Egberts, Carin M A Rademaker
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98348 (2014)
INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investi
Externí odkaz:
https://doaj.org/article/aede4028ddd948ac861abdb10be01b24
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72060 (2013)
BACKGROUND: The ICH E7 guideline intends to improve the knowledge about medicines in geriatric patients. As a legislative document, it might not reflect the needs of healthcare professionals. This study investigated what information healthcare profes
Externí odkaz:
https://doaj.org/article/c5f8773ead364c01b3f4e0f035a41a5d
Autor:
Thomas G, van Gelder, Arief, Lalmohamed, Irene J, van Diem-Zaal, Toine C G, Egberts, Arjen J C, Slooter
Publikováno v:
Intensive care medicine. 48(6)
Autor:
Nikki M F, Noorda, Bastiaan T G M, Sallevelt, Wivien L, Langendijk, Toine C G, Egberts, Eugène P, van Puijenbroek, Ingeborg, Wilting, Wilma, Knol
Publikováno v:
European geriatric medicine. 13(4)
Adverse drug reactions (ADRs) account for 10% of acute hospital admissions in older people, often under-recognised by physicians. The Dutch geriatric guideline recommends screening all acutely admitted older patients with polypharmacy with an ADR tri
Autor:
Helga Gardarsdottir, Matthijs L. Becker, Toine C. G. Egberts, Rosanne W. Meijboom, Thijs J. Giezen, Saskia ten Wolde
Publikováno v:
BioDrugs, 35(6). Adis International Ltd
Biodrugs
Biodrugs
Background Patients in clinical practice are transitioned from originator etanercept (OR-ETA) to biosimilar etanercept (BS-ETA), but some subsequently retransition. Insights into the incidence of and reasons for retransitioning and the characteristic
Autor:
Rutger Stuffken, Ralph Vreeswijk, Toine C. G. Egberts, Kees J. Kalisvaart, Madelon H. Butterhoff‐Terlingen, Monique P. H. Tillemans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa867bcfcfbdaa7a5262d5a24760c7cd
https://doi.org/10.1002/brb3.2404/v2/response1
https://doi.org/10.1002/brb3.2404/v2/response1